April 9, 2026
avatar-torie-bosch
First Opinion editor

The “First Opinion Podcast” is back for a new spring season, and we’re trying something a little different: This season, each episode will focus on the intersection of culture and medicine.

For the premiere episode, I spoke with Isaac Rose-Berman about his argument that the rise of sports betting may begat a public health crisis. Isaac, a fellow at the American Institute for Boys and Men, says that the explosion of sports betting has two kinds of threats: financial, as some wager their financial present (and future), and mental health, as compulsive behavior leads to anxiety, depression, and even suicide. Subscribe, take a listen, and let me know what other guests you’d like to hear this season.

Recommendation of the week: The first three episodes of “The Testaments,” the sequel to “The Handmaid’s Tale,” are out. So far, I’m enjoying it — particularly because we are getting far fewer (though not zero) closeups of Elisabeth Moss making intense/determined faces.



Molly Ferguson for STAT

STAT+ | Cardiology’s finally prioritizing prevention — but what will it look like?

At 2026’s biggest gathering of cardiologists, prevention was the buzzword — but it remains unclear how to actually deliver this care to people.

By Vishal Khetpal


Medical marijuana should not be recommended for PTSD, anxiety, or depression

38 U.S. states and the District of Columbia allow PTSD patients to get medical marijuana cards. But cannabis does not help PTSD.

By Kevin A. Sabet


How the next CDC director can win back America’s trust

Whoever the new CDC director is, they must restore trust in an institution that lost its way.

By Charles J. Lockwood, Robert C. Gallo, and Sten H. Vermund


Immunologist Barry Bloom, who recently died at 88, served as dean of the Harvard School of Public Health, where he remained on the faculty until his death.
Harvard T.H. Chan School of Public Health

Remembering public health pioneer Barry Bloom: a scientist, a mentor, a mensch

Barry R. Bloom brought rigor, integrity, and humanity to science and public health, pushing both forward by force of example and personality.

By Marc Lipsitch and Yonatan Grad


Subscription pricing could expand access to HIV prevention breakthrough while controlling costs

The breakthrough HIV prevention injection lenacapavir is particularly well suited for subscription pricing.

By Michael Rose


STAT+ | Washington is on the verge of true PBM reform

A bill in Congress and a proposed rule from the Department of Labor can rein in pharmacy benefit manager abuses, expert writes in STAT First Opinion.

By Neeraj Sood


Adobe

Medicare is restricting care for 1 million Americans based on a faulty assumption. Congress must intervene

CMS’ decision to limit access to appropriate ostomy supplies will not reduce costs. It shifts them downstream.

By Diego Schaps


My patient would rather take a peptide than a statin. That reveals an uncomfortable truth in medicine

With peptides like BPC-157, we are seeing 'the wholesale substitution of consumer enthusiasm for clinical evidence.'

By Vikas Patel


Medical misinformation wins when patients can’t see their doctors

Desperate patients, unable to get timely doctors’ appointments, seek help wherever they can find it.

By Ilana Yurkiewicz


Adobe

America needs more clinics of last resort for patients who can’t get answers

The NIH’s Undiagnosed Diseases Program should serve as a model for medical and research centers all over the country.

By Alexandra Sifferlin


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying First Opinion? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2026, All Rights Reserved.